Advertisement
Screener

CHINA BCT PHARMACY GROUP, INC. Operating Cash Flow

CHINA BCT PHARMACY GROUP, INC. Operating Cash Flow

CHINA BCT PHARMACY GROUP, INC. reported Operating Cash Flow of $2.66 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2013-05-20

  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2013-03-31 was $2.66M, a 71.93% increase year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was $1.15M.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was -$1.15M.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$11.13M, a 365.01% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for fiscal 2012 was -$9.59M.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for fiscal 2011 was -$5.13M, a 132.28% decline from fiscal 2010.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) operating activities for fiscal 2010 was $15.89M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2013-03-31$2.66M
10-Q · filed 2013-05-20
$3.81M
derived: sum of 2 quarters · filed 2013-05-20
$2.66M
derived: sum of 3 quarters · filed 2013-05-20
-$8.47M
derived: sum of 4 quarters · filed 2013-05-20
2012-12-31$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
-$4.12K
derived: sum of 2 quarters · filed 2013-04-15
-$11.14M
derived: sum of 3 quarters · filed 2013-04-15
-$9.59M
10-K · filed 2013-04-15
2012-09-30-$1.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
-$12.28M
derived: sum of 2 quarters · filed 2012-11-15
-$10.74M
10-Q · filed 2012-11-15
-$11.02M
derived: sum of 4 quarters · filed 2013-05-20
2012-06-30-$11.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
-$9.58M
10-Q · filed 2012-08-17
-$9.87M
derived: sum of 3 quarters · filed 2013-05-20
-$37.74M
derived: sum of 4 quarters · filed 2013-05-20
2012-03-31$1.55M
10-Q · filed 2013-05-20
$835.93K
10-Q · filed 2012-05-21
$1.26M
derived: sum of 2 quarters · filed 2013-05-20
-$26.61M
derived: sum of 3 quarters · filed 2013-05-20
-$22.41M
derived: sum of 4 quarters · filed 2013-05-20
2011-12-31-$287.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
-$28.15M
derived: sum of 2 quarters · filed 2013-04-15
-$23.95M
derived: sum of 3 quarters · filed 2013-04-15
-$5.13M
10-K · filed 2013-04-15
-$5.78M
10-K · filed 2012-03-30
2011-09-30-$27.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
-$23.67M
derived: sum of 2 quarters · filed 2012-11-15
-$4.84M
10-Q · filed 2012-11-15
$1.13M
derived: sum of 4 quarters · filed 2012-11-15
2011-06-30$4.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$23.03M
10-Q · filed 2012-08-17
$29.00M
derived: sum of 3 quarters · filed 2012-08-17
$32.93M
derived: sum of 4 quarters · filed 2012-08-17
2011-03-31$18.83M
10-Q · filed 2012-05-21
$24.80M
derived: sum of 2 quarters · filed 2012-06-12
$28.73M
derived: sum of 3 quarters · filed 2012-06-12
2010-12-31$5.97M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12
$9.90M
derived: sum of 2 quarters · filed 2012-06-12
$15.89M
10-K/A · filed 2012-06-12
2010-09-30$3.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$9.92M
10-Q · filed 2011-11-14
2010-06-30$5.99M
10-Q · filed 2011-08-15